177 related articles for article (PubMed ID: 1410939)
1. [Studies on purine-pyrimidine metabolism (1)--Quantitation of purine-pyrimidine metabolites and allopurinol-oxipurinol in biological fluids].
Hiroshige K; Kunifuji Y; Takasugi M; Kuroiwa A
J UOEH; 1992 Sep; 14(3):211-8. PubMed ID: 1410939
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous liquid chromatography of 5-fluorouracil, uridine, hypoxanthine, xanthine, uric acid, allopurinol, and oxipurinol in plasma.
Wung WE; Howell SB
Clin Chem; 1980 Nov; 26(12):1704-8. PubMed ID: 7428153
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of allopurinol, oxipurinol, hypoxanthine and xanthine in biological fluids by high-performance liquid chromatography.
Boulieu R; Bory C; Baltassat P; Gonnet C
J Chromatogr; 1984 May; 307(2):469-74. PubMed ID: 6736196
[No Abstract] [Full Text] [Related]
4. Liquid chromatography with multichannel ultraviolet detection used for studying disorders of purine metabolism.
Kojima T; Nishina T; Kitamura M; Kamatani N; Nishioka K
Clin Chem; 1987 Nov; 33(11):2052-6. PubMed ID: 3677379
[TBL] [Abstract][Full Text] [Related]
5. Reversed-phase liquid-chromatographic determination of purine compounds in serum applied to studies of hypouricemia.
Kojima T; Nishina T; Kitamura M; Kamatani N; Nishioka K
Clin Chem; 1986 Feb; 32(2):287-90. PubMed ID: 3943189
[TBL] [Abstract][Full Text] [Related]
6. A high-performance liquid chromatographic method for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum.
Kock R; Delvoux B; Greiling H
Eur J Clin Chem Clin Biochem; 1993 May; 31(5):303-10. PubMed ID: 8357939
[TBL] [Abstract][Full Text] [Related]
7. Plasma oxipurinol concentrations during allopurinol therapy.
Emmerson BT; Gordon RB; Cross M; Thomson DB
Br J Rheumatol; 1987 Dec; 26(6):445-9. PubMed ID: 3690140
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of hypoxanthine in plasma from patients with ischemic heart disease: adaption of a high-performance liquid chromatographic method.
Himmel HM; Sadony V; Ravens U
J Chromatogr; 1991 Jul; 568(1):105-15. PubMed ID: 1770088
[TBL] [Abstract][Full Text] [Related]
9. The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.
Chalmers RA; Parker R; Simmonds HA; Snedden W; Watts RW
Biochem J; 1969 May; 112(4):527-32. PubMed ID: 5801674
[TBL] [Abstract][Full Text] [Related]
10. Studies on the purine-pyrimidine metabolism (2)--Effects of sample preparation and diet on the concentrations of oxypurines in blood and urine.
Hiroshige K; Takasugi M; Yuu K; Kuroiwa A
J UOEH; 1994 Jun; 16(2):167-78. PubMed ID: 8016487
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of guanine, uric acid, hypoxanthine and xanthine in human plasma by reversed-phase high-performance liquid chromatography with amperometric detection.
Liu Z; Li T; Wang E
Analyst; 1995 Aug; 120(8):2181-4. PubMed ID: 7677251
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatography with polarographic and voltammetric anodic detection: simultaneous determination of allopurinol, oxipurinol and uric acid in body fluids.
Palmisano F; Desimoni E; Zambonin PG
J Chromatogr; 1984 Mar; 306():205-14. PubMed ID: 6715459
[TBL] [Abstract][Full Text] [Related]
13. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
[TBL] [Abstract][Full Text] [Related]
14. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
Bory C; Chantin C; Boulieu R
Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
[No Abstract] [Full Text] [Related]
15. [The influence of allopurinol on purine- and pyrimidinesynthesis (author's transl)].
Gröbner W; Zöllner N
Klin Wochenschr; 1978 Mar; 53(16):255-60. PubMed ID: 682520
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic determination of hypoxanthine and xanthine in biological fluids.
Boulieu R; Bory C; Baltassat P; Gonnet C
J Chromatogr; 1982 Dec; 233():131-40. PubMed ID: 6897651
[TBL] [Abstract][Full Text] [Related]
17. Allopurinol metabolism in a patient with xanthine oxidase deficiency.
Yamanaka H; Nishioka K; Suzuki T; Kohno K
Ann Rheum Dis; 1983 Dec; 42(6):684-6. PubMed ID: 6689118
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of allopurinol and oxipurinol in human plasma and urine by high-performance liquid chromatography.
de Vries JX; Voss A; Kutschker C; Reiter S
Arzneimittelforschung; 1993 Oct; 43(10):1072-5. PubMed ID: 8267672
[TBL] [Abstract][Full Text] [Related]
19. [A study on treatment of hyperuricemia--effects and kinetics of allopurinol and oxipurinol].
Hosoya T; Ichida K; Tabe A; Sakai O
Ryumachi; 1991 Feb; 31(1):28-35. PubMed ID: 1857993
[TBL] [Abstract][Full Text] [Related]
20. An isocratic, reversed-phase HPLC method for the determination of postischemic efflux of purines and pyrimidines during reperfusion of isolated liver.
Toshchakov VY; Bashkina LV; Onishchenko NA; Shumakov VI
Biochemistry (Mosc); 1998 Feb; 63(2):219-23. PubMed ID: 9526118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]